Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Wave Life Sciences (WVE) Shares Outstanding (Diluted Average): 2021-2025

Historic Shares Outstanding (Diluted Average) for Wave Life Sciences (WVE) over the last 5 years, with Sep 2025 value amounting to $167.7 million.

  • Wave Life Sciences' Shares Outstanding (Diluted Average) rose 26.54% to $167.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $167.7 million, marking a year-over-year increase of 26.54%. This contributed to the annual value of $138.3 million for FY2024, which is 30.33% up from last year.
  • Wave Life Sciences' Shares Outstanding (Diluted Average) amounted to $167.7 million in Q3 2025, which was up 2.29% from $164.0 million recorded in Q2 2025.
  • Wave Life Sciences' Shares Outstanding (Diluted Average)'s 5-year high stood at $167.7 million during Q3 2025, with a 5-year trough of $50.0 million in Q2 2021.
  • Over the past 3 years, Wave Life Sciences' median Shares Outstanding (Diluted Average) value was $131.0 million (recorded in 2024), while the average stood at $133.8 million.
  • Data for Wave Life Sciences' Shares Outstanding (Diluted Average) shows a peak YoY soared of 85.17% (in 2022) over the last 5 years.
  • Over the past 5 years, Wave Life Sciences' Shares Outstanding (Diluted Average) (Quarterly) stood at $51.8 million in 2021, then surged by 52.16% to $78.9 million in 2022, then spiked by 34.55% to $106.1 million in 2023, then soared by 30.33% to $138.3 million in 2024, then rose by 26.54% to $167.7 million in 2025.
  • Its last three reported values are $167.7 million in Q3 2025, $164.0 million for Q2 2025, and $162.5 million during Q1 2025.